1993 JAN 01 COVID 19 & Obesity Comorbidity linked with Zinc Deficiency, Companion Medication (HCQ + Zinc)

Why is ZINC with HCQ important in treatment for COVID-19 and has Comorbidity of Obesity , Zinc Deficiency is linked to the Comorbidity of Obesity and the hydroxychloroquine, “opens the zinc channel” allowing the zinc to enter the cell, which then “blocks the replication of cellular machinery.” In this instance, chloroquine has no drug action. It is the zinc that is in play. Continue Reading